Clinical Trial Update: A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating LY3502970 in Chinese participants who are overweight or have obesity with weight-related conditions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• LY3502970

Snippet

Sponsor: Eli Lilly and Company | Conditions: Overweight, Obesity | Phase 1 | Status: COMPLETED